AUPH Aurinia Pharmaceuticals Inc

$5.6 +2.56%

753,566 Shares Traded
908,224 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $1.31 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-12.58%
If Intiated One Month Ago, Shorts Have Realized a Return of:5.86%
If Initiated Five Days ago, Shorts Have Realized a Return of:-3.21%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 11.14%
Short Interest9.36 million
Float84.05 million
Short Ratio8.67
Market Cap$458.92 million
Market Maker ActivityDaily Short Volume

News

02-22-2018
Aurinia Enhances Research, Development, and Scientific Expertise with the Appointment of Michael Hayden to its Board of Directors (Business Wire)
02-20-2018
Aurinia Named Company of the Year by LifeSciences BC (Business Wire)
02-16-2018
Aurinia Pharmaceuticals: Will AURORA Light The Way To Voclosporin's Approval? (SeekingAlpha)
02-14-2018
Aurinia Pharmaceuticals Launches New Lupus Nephritis Disease Awareness Program (Business Wire)
02-08-2018
Premarket analyst action - healthcare (SeekingAlpha)
02-08-2018
Aurinia Enhances Commercial and Business Development Expertise with the Appointment of Joseph P. Hagan to its Board of Directors (Business Wire)
02-06-2018
Aurinia to Present at Leerink Partners 7th Annual Global Healthcare Conference (Business Wire)
01-26-2018
Aurinia Pharmaceuticals: Potential Rewards Far Outweigh The Risks (SeekingAlpha)
01-25-2018
Aurinia Pharmaceuticals' Voclosporin: A Blockbuster Drug Hidden In Plain Sight? (SeekingAlpha)
01-22-2018
Bristol-Myers Squibb's Abatacept Compared Against Aurinia Pharmaceuticals' Voclosporin In The Treatment Of Lupus Nephritis Patients (SeekingAlpha)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 49.3%

Earnings Stats

PE Ratio -8.95
Dividend Yield 0%
Peer EarningsEarnings Calendar

Technicals

200 Day Moving Average $5.95
50 Day Moving Average $5.17
52 Week High $10.54
52 Week Low $3.23



Data provided for free by IEX. Questions? Read the FAQ